Expression of (pro)renin receptor in breast cancers and its effect on cancercell proliferation
-
- OHBA Koji
- Department of Endocrinology and Applied Medical Science, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi,Aoba-ku, Sendai, Miyagi, 980-8575, Japan
-
- SUZUKI Takashi
- Department of Pathology and Histotechnology, Tohoku University Graduate School ofMedicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan
-
- NISHIYAMA Hiroshi
- Department of Endocrinology and Applied Medical Science, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi,Aoba-ku, Sendai, Miyagi, 980-8575, Japan
-
- KANEKO Kiriko
- Department of Endocrinology and Applied Medical Science, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi,Aoba-ku, Sendai, Miyagi, 980-8575, Japan
-
- HIROSE Takuo
- Department of Planning for Drug Development and ClinicalEvaluation, Tohoku University Graduate School of Pharmaceutical Sciences and Medicine, Miyagi 980-8575, Japan
-
- TOTSUNE Kazuhito
- Department of Planning for Drug Development and ClinicalEvaluation, Tohoku University Graduate School of Pharmaceutical Sciences and Medicine, Miyagi 980-8575, Japan Department ofSocial Welfare, Faculty of Synthetic Welfare, Tohoku Fukushi University, 1-8-1 Kunimi, Aoba-ku, Sendai, Miyagi 981-8522, Japan
-
- SASANO Hironobu
- Department of Anatomic Pathology, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi,980-8575, Japan
-
- TAKAHASHI Kazuhiro
- Department of Endocrinology and Applied Medical Science, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi,Aoba-ku, Sendai, Miyagi, 980-8575, Japan
この論文をさがす
抄録
(Pro)renin receptor ((P)RR) is a specific receptor for renin and prorenin. The aim of the presentstudy is to clarify expression of (P)RR and pathophysiological roles of (P)RR in human breastcarcinomas. (P)RR expression was studied in 69 clinical cases of breast carcinoma by immunohistochemistry.Effects of (P)RR on cell proliferation were examined in cultured human breast carcinomacells using (P)RR specific small interference RNA. Immunohistochemistry showed that(P)RR immunoreactivity was detected in the breast carcinoma cells in 50 of 69 cases of breastcarcinoma (72%). The analysis on association between (P)RR immunoreactivity and clinicopathologicalparameters showed that the number of (P)RR positive cases was significantly greater inKi-67 (a cell proliferation marker) ≥ 10% group than in Ki-67 < 10% group (P = 0.02). (P)RR wasexpressed in 4 types of human breast carcinoma cell lines. (P)RR specific small interference RNAinhibited proliferation of both MCF-7 (ERα positive) and SK-BR-3 (ERα negative) cells. Thepresent study has shown, for the first time, the expression of (P)RR in human breast carcinomatissues and cultured breast carcinoma cell lines. These findings have raised the possibility that theblockade of the (P)RR signaling may be a novel therapeutic strategy against breast carcinomas.
収録刊行物
-
- Biomedical Research
-
Biomedical Research 35 (2), 117-126, 2014
バイオメディカルリサーチプレス